The results of this study indicated that WS-PE exerted antidiabetic effects by activating Akt/GLUT4 and Akt/GSK3β and further ameliorating insulin resistance, hyperglycemia, and dyslipidemia. The gene discussed is SLC2A4; the disease is metabolic syndrome.